Effective biotechnology governance depends on alignment between science and policy, national systems and international frameworks. Shared sequence-screening standards help regulators and innovators operate with clarity, consistency, and mutual trust.

Andy Morgan is a Senior Policy Advisor at New Zealand’s Ministry of Business, Innovation & Employment (MBIE), where he works on biotechnology policy and regulatory frameworks at the intersection of science, innovation and international engagement. His role focuses on ensuring that New Zealand’s biotechnology ecosystem develops in a way that is safe, responsible, and internationally aligned, while supporting research excellence and economic growth.

Andy brings experience in translating complex scientific and technical developments into pragmatic policy and regulatory approaches. His work contributes to national and international discussions on emerging biotechnologies, risk governance, and regulatory coordination, ensuring that policy keeps pace with advances in areas such as synthetic biology, genetic technologies, and biosecurity-relevant innovation. Through this lens, he supports New Zealand’s engagement in global standards-setting and multilateral cooperation on biotechnology oversight.